Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Henner Knust, Rheinfelden DE

Henner Knust, Rheinfelden DE

Patent application numberDescriptionPublished
20080221166AMINOAMIDES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula I09-11-2008
20080249125HETEROCYCLIC DERIVATIVES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula10-09-2008
20080249180MALONAMIDES AS OREXIN ANTAGONISTS - The present invention relates to compounds of formula I10-09-2008
20080275021PYRROLIDINE DERIVATIVES AS DUAL NK1/NK3 RECEPTOR ANTAGONISTS - The invention relates to pyrrolidine derivatives of formula11-06-2008
20080306086PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS - The present invention relates to a compound of formula I12-11-2008
20080306089PROLINAMIDE-TETRAZOLE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to a compound of formula I12-11-2008
20080312216PIPERAZINE AND [1,4]DIAZEPAN DERIVATIVES AS NK ANTAGONISTS - The present invention relates to a compound of formula I12-18-2008
20090005370ISOXAZOLE-IMIDAZOLE DERIVATIVES - The present invention is concerned isoxazole-imidazole derivatives having affinity and selectivity for GABA A α5 receptor binding site, their manufacture, pharmaceutical compositions containing them and their use for enhancing cognition or for the treatment of cognitive disorders like Alzheimer's disease. In particular, the present invention is concerned with aryl-isoxazol-4-yl-imidazole derivatives of formula I01-01-2009
20090036422MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula02-05-2009
20090042896PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS - The invention relates to a compound of formula I02-12-2009
20090054644PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS - The invention relates to a compound of general formula02-26-2009
20090076081PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS - The invention relates to a compound of formula03-19-2009
20090143371ISOXAZOLE-PYRIDINE DERIVATIVES - The present invention is concerned with isoxazole-pyridine derivatives of formula I06-04-2009
20090143385ISOXAZOLO-PYRIDAZINE DERIVATIVES - The invention relates to isoxazolo-pyridazine compounds, in particular those of formula I as described above and to a pharmaceutically acceptable salts thereof, having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, pharmaceutical compositions containing them and their use as cognitive enhancers or for the treatment of cognitive disorders like Alzheimer's disease.06-04-2009
20090143407ISOXAZOLO-PYRAZINE DERIVATIVES - The invention relates to isoxazolo-pyrazine derivatives and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, and pharmaceutical compositions containing them. The compounds of present invention are inverse agonists of GABA A α5. The invention also relates to methods for enhancing cognition and for treating cognitive disorders like Alzheimer's disease.06-04-2009
20090163485HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula06-25-2009
20090197875ARYL-ISOXAZOLO-4-YL-OXADIAZOLE DERIVATIVES - The present invention is concerned with isoxazol-4-yl-oxadiazole derivatives of formula08-06-2009
20090203736PIPERIDINE SULPHONAMIDE DERIVATIVES - The present invention relates to piperidine sulphonamide derivatives of formula08-13-2009
20090306043PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula I12-10-2009
20090312314HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula12-17-2009
20090312327PYRROLIDINE DERIVATIVES AS NK2 RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula I12-17-2009
20100029664PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula I02-04-2010
20100041886ISOXAZOLO-PYRAZINE DERIVATIVES - The invention relates to isoxazolo-pyrazine derivatives and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, and pharmaceutical compositions containing them. The compounds of present invention are inverse agonists of GABA A α5. The invention also relates to methods for enhancing cognition and for treating cognitive disorders like Alzheimer's disease.02-18-2010
20100075954SUBSTITUTED IMIDAZO[1,5-A][1,2,4]TRIAZOLO[1,5-D][1,4]BENZODIAZEPINE DERIVATIVES - The present invention is concerned with a method of treating Alzheimer's disease by administering a therapeutically effective amount of a substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine of formula I03-25-2010
20100113424N-BENZYL PYRROLIDINE DERIVATIVES - The present invention relates to a compound of formula I05-06-2010
20100125078QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to a compounds of formula I05-20-2010
20100168088PYRROLIDINE DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS - The present invention relates to a compound of formula I07-01-2010
20100197697PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to a compounds of formula I08-05-2010
20100210659PYRROLIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to a compounds of formula I08-19-2010
20100286117PYRIDINES - The present invention is concerned with novel isoxazoles of formula I11-11-2010
20110021565PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS - The invention relates to a compound of formula01-27-2011
20110053948PYRROLIDINES AS NK3 RECEPTOR ANTAGONISTS - The present invention relates to a compounds of formula I03-03-2011
20110071154PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula I03-24-2011
20110144081PYRROLIDINE DERIVATIVES - The present invention relates to compounds of formula06-16-2011
20110152233PYRROLIDINE COMPOUNDS - The present application relates to compounds of formula06-23-2011

Patent applications by Henner Knust, Rheinfelden DE